These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36936916)

  • 1. Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma.
    Xu L; Gao X; Xing J; Guo Z
    Front Immunol; 2023; 14():1118816. PubMed ID: 36936916
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and validation of necroptosis-related prognostic gene signature and tumor immune microenvironment infiltration characterization in esophageal carcinoma.
    Sun K; Hong JJ; Chen DM; Luo ZX; Li JZ
    BMC Gastroenterol; 2022 Jul; 22(1):344. PubMed ID: 35840882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of a necroptosis-related prognostic gene signature associated with tumor immune microenvironment in cervical carcinoma and experimental verification.
    Sun K; Huang C; Li JZ; Luo ZX
    World J Surg Oncol; 2022 Oct; 20(1):342. PubMed ID: 36253777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel mutation gene signature HAMP for cholangiocarcinoma through comprehensive TCGA and GEO data mining.
    Wang Z; Du Y
    Int Immunopharmacol; 2021 Oct; 99():108039. PubMed ID: 34426102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma.
    Tao Q; Lang Z; Li Y; Gao Y; Lin L; Yu Z; Zheng J; Yu S
    BMC Cancer; 2023 Oct; 23(1):1029. PubMed ID: 37875823
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and validation of a prognostic signature based on necroptosis-related genes in hepatocellular carcinoma.
    Peng YL; Wang LX; Li MY; Liu LP; Li RS
    PLoS One; 2023; 18(2):e0279744. PubMed ID: 36795724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Prognostic Predictor of Immune Microenvironment and Therapeutic Response in Kidney Renal Clear Cell Carcinoma based on Necroptosis-related Gene Signature.
    Chen W; Lin W; Wu L; Xu A; Liu C; Huang P
    Int J Med Sci; 2022; 19(2):377-392. PubMed ID: 35165523
    [No Abstract]   [Full Text] [Related]  

  • 8. Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.
    Jin H; Liu W; Xu W; Zhou L; Luo H; Xu C; Chen X; Chen W
    Comput Math Methods Med; 2022; 2022():7102736. PubMed ID: 36158120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potential prognosis index for m
    Zhu H; Zhao H; Wang J; Zhao S; Ma C; Wang D; Gao H; Yang F; Ni Q; Li H; Zhou X; Zhang C; Lu J
    BMC Cancer; 2022 Jun; 22(1):620. PubMed ID: 35672673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An Efficient Signature Based on Necroptosis-Related Genes for Prognosis of Patients With Pancreatic Cancer.
    Shi H; Peng Q; Zhou X; He Y; Sun S
    Front Genet; 2022; 13():848747. PubMed ID: 35419022
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification and Validation of Prognostic Model for Pancreatic Ductal Adenocarcinoma Based on Necroptosis-Related Genes.
    Xie H; Xu J; Xie Z; Xie N; Lu J; Yu L; Li B; Cheng L
    Front Genet; 2022; 13():919638. PubMed ID: 35783277
    [No Abstract]   [Full Text] [Related]  

  • 12. Identification of a necroptosis-related gene signature for making clinical predictions of the survival of patients with lung adenocarcinoma.
    Zhou X; Zhao M; Fan Y; Xu Y
    PeerJ; 2024; 12():e16616. PubMed ID: 38213773
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a necroptosis-related gene signature and the immune landscape in ovarian cancer.
    Nie S; Ni N; Chen N; Gong M; Feng E; Liu J; Liu Q
    J Ovarian Res; 2023 Apr; 16(1):82. PubMed ID: 37095524
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma.
    Liu S; Fan S; Wang Y; Chen R; Wang Z; Zhang Y; Jiang W; Chen Y; Xu X; Yu Y; Li C; Li X
    BMC Cancer; 2023 May; 23(1):444. PubMed ID: 37193981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A metabolism-related 4-lncRNA prognostic signature and corresponding mechanisms in intrahepatic cholangiocarcinoma.
    Zou W; Wang Z; Wang F; Li L; Liu R; Hu M
    BMC Cancer; 2021 May; 21(1):608. PubMed ID: 34034689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comprehensive pan-cancer analysis of necroptosis molecules in four gynecologic cancers.
    Zheng J; Cai X; Zhang Y; Wang H; Liu L; Tang F; Liu L; Sun Y
    BMC Cancer; 2022 Nov; 22(1):1160. PubMed ID: 36357839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and Validation of a Prognostic Model for Esophageal Adenocarcinoma Based on Necroptosis-Related Genes.
    Zhang S; Liu S; Lin Z; Zhang J; Lin Z; Fang H; Hu Z
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of necroptosis-related genes for evaluating immune infiltration and colon cancer prognosis.
    Yang W; Lu S; Peng L; Zhang Z; Zhang Y; Guo D; Ma F; Hua Y; Chen X
    Front Immunol; 2022; 13():1085038. PubMed ID: 36618366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel necroptosis signature for predicting survival in lung adenocarcinoma.
    Zang K; Wang M; Zhu X; Yao B; Huang Y
    BMC Med Genomics; 2023 Nov; 16(1):305. PubMed ID: 38017445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.